Home > Insider Trading > Filing (0001209191-21-036354)

Filing Details

Accession Number:: 0001209191-21-036354
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-27 19:55:28
Reporting Period:: 2021-05-25

Accepted Time:: 2021-05-27 19:55:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1808158	Repare Therapeutics Inc.	RPTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1473930	Todd Foley	C/O Mpm Capital 450 Kendall Street Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2021-05-25	2,852	$32.87	2,414,595	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-25	44	$33.59	2,414,551	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-26	9,839	$32.74	2,404,712	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-26	751	$33.01	2,403,961	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-27	1,906	$32.81	2,402,055	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-27	1,597	$33.16	2,400,458	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on 3/31/2021.
The shares were sold as follows: 2,756 by MPM BioVentures 2014, L.P. ("BV 2014") and 96 by MPM Asset Management Investors BV2014 LLC ("AM BV2014").
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.45 to $33.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,202,927 by BV 2014, 135,843 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 75,825 by AM BV2014. MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV LLC is the manager of AM BV2014. Todd Foley is a managing director of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 43 by BV 2014 and 1 by AM BV2014.
The shares are held as follows: 2,202,884 by BV 2014, 135,843 by BV 2014(B) and 75,824 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 9,512 by BV 2014 and 327 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.955 to $32.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,193,372 by BV 2014, 135,843 by BV 2014(B) and 75,497 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 726 by BV 2014 and 25 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.98 to $33.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,192,646 by BV 2014, 135,843 by BV 2014(B) and 75,472 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 1,843 by BV 2014 and 63 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.07 to $33.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,190,803 by BV 2014, 135,843 by BV 2014(B) and 75,409 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 1,544 by BV 2014 and 53 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.075 to $33.59 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,189,259 by BV 2014, 135,843 by BV 2014(B) and 75,356 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.